MECP2 and Alzheimer disease: Taken together, these observations suggest that MeCP2 contributes to REST gene silencing in MCI and AD by binding to DNMT1 and excluding β-catenin from the DNMT1-β-catenin complex and not by its interaction with the mSin3A-HDAC1/2 complex.